Shin CAR T-Cell Ana Samun Farfawar Kwayoyin cuta A Indiya?

CAR T-Cell Therapy A Indiya

Share Wannan Wallafa

Shin kun taɓa tunanin ko akwai wata hanya mai ƙarfi don yaƙi da cutar kansa?

Yanzu kawai ka yi tunanin idan wata rana ka sami haske na bege a cikin yaƙin ku da kansa, magani wanda ke amfani da ikon tsarin garkuwar jikin ku don kai hari da lalata ƙwayoyin cutar kansa. Alkawarin kenan CAR T-Cell Far.

Wani babban nasara ne na kimiyyar likitanci wanda ke canza yadda muke yaƙar wannan cuta mai ban tsoro. Yanzu babbar tambaya ta zo: Ana samun maganin CAR T-cell a Indiya?

Ko kai ko masoyinka ne ke yaƙar wannan muguwar cuta, kada ka yi fata. Za mu iya fahimtar zafi da tsoro da kuke ɗauka a cikin zuciyar ku da tunanin ku. Shi ya sa muke shirin ba ku amsoshin da kuke nema tun kwanaki.

CAR T Cell Therapy A Indiya

A cikin wannan shafi mai zurfi, za mu tattauna yadda wannan jiyya mai ban mamaki - CAR T Cell far in India yana canza yanayin duka a cikin kula da kansa. Za mu gano: Shin CAR T-cell far yana samuwa a Indiya don ku ko ƙaunataccen?

Mun zo nan don taimaka muku kowane mataki na hanya, daga sanin yadda yake aiki zuwa gano inda zaku iya samu CAR T Jiyya na ƙwayar cuta a Indiya. Kasance tare da mu a wannan tafiya mai fa'ida don samun kyakkyawar makoma a yaƙi da cutar kansa.

Ka ci gaba da maimaita kowace rana a zuciyarka, “Na fi ƙarfi ciwon daji domin ina da ƙauna, da bege, da ruhun faɗa.” Waɗannan kalmomi masu sauƙi suna da ikon canza yadda kuke ganin duniya yayin ciwon daji.

Menene CAR-T Cell Therapy kuma Yaya Aiki yake?

Tsarin garkuwar jikin ku yana aiki kamar mai tsaro na 24/7 kuma yana lura da kowane sinadari da ke cikin jikin ku. Don haka, a duk lokacin da ta sami wani baƙon abu a cikin jikinka, yana haifar da tsarin garkuwar jiki don kai hari.

It is a remarkable treatment to get immune cells from your body, which can help you fight against cancer. CAR-T treatment has shown extraordinary success in treating certain types of blood cancers, especially leukemia or linzoma.

Bincike ya nuna cewa marasa lafiya da ba su amsa maganin gargajiya kamar chemotherapy ko radiation ba sun sami babban taimako daga wannan maganin.

CAR T Cell Therapy A Indiya

Ga yadda yake aiki:

Tarin T-Cell:

Tsarin yana farawa lokacin da likitan ku ya tattara ƙwayoyin T daga jinin ku ta hanyar da ake kira leukapheresis. Waɗannan ƙwayoyin T sune nau'in farin jini wanda ke taka muhimmiyar rawa a cikin tsarin rigakafi.

Suna amfani da bututu da aka saka a cikin jijiya a hannunka don tattara jinin, wanda ya ƙunshi ƙwayoyin T. Wannan tsari na iya ɗaukar har zuwa sa'o'i 2-3.

Gyaran Halitta:

Kwayoyin T da aka tattara suna fuskantar gyare-gyaren kwayoyin halitta a cikin dakin gwaje-gwaje don samar da Chimeric Antigen Receptor (CAR) a saman su. Wannan CAR furotin ne na wucin gadi wanda aka ƙera shi don gano wani nau'in furotin da ke kan saman sel masu ciwon daji.

Samar da Kwayoyin CAR-T:

Bayan haka, ƙwayoyin T da aka canza suna faɗaɗa kuma suna ƙara girma. Sakamakon haka, an samar da ƙwayoyin CAR-T da yawa waɗanda zasu iya yin niyya ta musamman akan furotin da ke saman naku ciwon daji Kwayoyin.

Jiko:

Da zarar an samar da isassun adadin ƙwayoyin CAR-T, za a dawo da su cikin jini ta hanyar ɗigo, kamar ƙarin jini.

Yin Nufin Ƙwayoyin Cutar Cancer:

Kamar yadda ƙwayoyin CAR-T ke yawo a cikin jikin mai haƙuri, suna neman ƙwayoyin kansa. Lokacin da suka haɗu da ƙwayoyin kansa waɗanda ke da ainihin furotin da CAR ke nufi, suna kunnawa.

Hari Kan Kwayoyin Cancer:

Lokacin da aka kunna, ƙwayoyin CAR-T suna ƙaddamar da wani hari mai ƙarfi kuma takamaiman akan ƙwayoyin cutar kansa. Suna sakin sinadarai da enzymes da ke sa ƙwayoyin kansa su mutu.

Dagewa da Ƙwaƙwalwa:

Bayan jiyya ta farko, wasu ƙwayoyin CAR-T na iya kasancewa a cikin jikin ku. Za su iya ci gaba da nema da kai hari kan ƙwayoyin cutar kansa, suna ba ku kariya ta dogon lokaci daga dawowar cutar kansa.

Wanene Yake Samun Maganin CAR-T?

CAR-T Cell Therapy is a specialized treatment for cutar kansa patients. It’s like giving your body’s fighters, known as T cells, a tremendous boost. But then the question arises: Who gets this powerful treatment?

Yawancin lokaci ya fi dacewa ga masu ciwon daji waɗanda suka gwada wasu jiyya waɗanda ba su yi aiki ba.

Alal misali, ana la'akari da shi ga mutanen da ke da babban lymphoma B-cell (DBCL) ko na farko na tsakiya na B-cell lymphoma (PMBCL) idan lymphoma ya girma duk da akalla biyu hanyoyin kwantar da hankali.

Similarly, children and adults with B-cell m lymphoblastic cutar sankarar bargo who have not responded to traditional therapies may receive this therapy.

CAR T Cell Therapy A Indiya

A wasu lokuta, CAR-T far na iya zama zaɓi ga mutanen da ke da DLBCL waɗanda suka sake komawa da sauri bayan layin farko na chemotherapy ko kuma waɗanda ke da tsayayya ga wannan magani na farko.

Ka tuna cewa ba kai kaɗai ba ne a cikin wannan yaƙin, kuma akwai zaɓuɓɓuka da ke akwai don taimaka maka fuskantar kansa da ƙarfin hali da azama.

Shin CAR T-Cell Ana Samun Farfawar Kwayoyin cuta A Indiya?

Bari mu zo ga babban batu yanzu - Ana samun maganin CAR T-cell a Indiya?

Masu fama da cutar daji a Indiya za su sami labari mai daɗi a watan Oktoba 2023. Wannan watan ya kawo farin ciki da bege ga iyalan masu fama da cutar kansa.

Cibiyar Kula da Ma'aunin Magunguna ta Tsakiya (CDSCO) kwanan nan ta amince da NexCAR19, jiyya ta ƙwayoyin CAR-T ta asali. ImmunoACT tare da haɗin tare da Cibiyar Tunawa da Tata (TMC).

Abin da ya fi ƙarfafawa shi ne cewa wannan magani za a yi farashi mai inganci idan aka kwatanta da sauran ƙasashe. Kuna iya tsammanin wannan ci gaba na maganin ciwon daji zai zama ƙasa da $ 57,000 USD. Wannan yana ba da sabon bege ga dubban marasa lafiya da ke da lymphomas na B-cell a Indiya, yayin da za a sami damar yin amfani da maganin a kusan asibitoci 20 na gwamnati da masu zaman kansu a cikin manyan biranen.

With the assistance of a Malaysian company, certain cancer centers in India have already started CAR T-Cell therapy for various types of cancers in August 2023 which includes DLBCL, BALL, Multiple Myeloma, Gliomas, as well as liver, pancreatic, colon, lung, cervical, and GI-based cancers.

Wani babban mataki ne na samar da ci-gaban maganin ciwon daji mafi sauki kuma mai araha ga kowa. Tare da irin wannan babban labari, yakamata ku zama masu ƙarfi fiye da kowane lokaci don yaƙi da cutar kansa kuma ku kayar da shi tare da ƙudurin ku na tsira.

Da fatan. Wataƙila kun sami amsar "Shin ana samun maganin CAR T-cell a Indiya?" Idan eh, tuntuɓi Fax na Cancer don karɓar mafi kyawun kulawar cutar kansa.

Ta yaya Fax Cancer Zai Taimaka muku?

A CancerFax, mun fahimci cewa ma'amala da ciwon daji na iya zama mai wahala da ƙwarewa. Shi ya sa muke nan tare da buɗaɗɗen zukata da tunani masu tausayi, a shirye muke mu tallafa muku kowane mataki na hanya.

Manufarmu ita ce haɗa ku ko ƙaunataccen ku da ke fama da ciwon daji tare da ingantattun hanyoyin kwantar da hankali, gami da ƙarfin CAR-T Cell Therapy.

Ba mu kawai a nan don samar da bayanai ba; mun zo nan don ba da hannun taimako, kunnen sauraro, da tushen ci gaba da goyan bayan wannan tafiya mai wahala.

Kamar yadda ake cewa, 'Kowace guguwa ta kare daga ruwan sama.' Ka tuna cewa kuna da ƙarfi don tsira daga wannan guguwar, kuma muna nan don taimaka muku nemo hanyarku zuwa mafi kyawun kwanaki masu zuwa.

Jin kyauta don tuntuɓar mu kowane lokaci a + 91 96 1588 1588 if you have any queries regarding the treatment or require shawarwari kan layi from top oncologists.

Biyan kuɗi zuwa ga Newsletter

Sami sabuntawa kuma kada ku rasa bulogi daga Cancerfax

Toarin Don Bincika

Lutetium Lu 177 dotatate an amince da shi ta USFDA don marasa lafiya na yara masu shekaru 12 da haihuwa tare da GEP-NETS
Cancer

Lutetium Lu 177 dotatate an amince da shi ta USFDA don marasa lafiya na yara masu shekaru 12 da haihuwa tare da GEP-NETS

Lutetium Lu 177 dotatate, magani mai ban sha'awa, kwanan nan ya sami izini daga Hukumar Abinci da Magunguna ta Amurka (FDA) ga marasa lafiya na yara, wanda ke nuna gagarumin ci gaba a cikin ilimin cututtukan cututtukan yara. Wannan amincewar tana wakiltar alamar bege ga yara masu fama da ciwace-ciwacen ƙwayoyin cuta na neuroendocrine (NETs), nau'in ciwon daji da ba kasafai ba amma ƙalubale wanda galibi ke tabbatar da juriya ga hanyoyin warkewa na al'ada.

USFDA ta amince da Nogapendekin alfa inbakicept-pmln don cutar kansar mafitsara mara tsoka da BCG.
Ciwon daji na bladder

USFDA ta amince da Nogapendekin alfa inbakicept-pmln don cutar kansar mafitsara mara tsoka da BCG.

“Nogapendekin Alfa Inbakicept-PMLN, wani labari na rigakafi, yana nuna alƙawarin magance cutar kansar mafitsara idan aka haɗa shi da maganin BCG. Wannan sabuwar dabarar ta shafi takamaiman alamomin cutar kansa yayin da ake ba da amsa ga tsarin rigakafi, yana haɓaka ingancin jiyya na gargajiya kamar BCG. Gwajin gwaje-gwaje na asibiti suna bayyana sakamako masu ƙarfafawa, yana nuna ingantattun sakamakon haƙuri da yuwuwar ci gaba a cikin sarrafa kansar mafitsara. Haɗin kai tsakanin Nogapendekin Alfa Inbakicept-PMLN da BCG yana sanar da sabon zamani a cikin maganin cutar kansar mafitsara."

Ana buƙatar taimako? Ourungiyarmu a shirye take don taimaka muku.

Muna fatan samun lafiya cikin sauri na masoyinku da na kusa.

Fara hira
Muna Kan layi! Yi Taɗi da Mu!
Duba lambar
Hello,

Barka da zuwa CancerFax!

CancerFax wani dandali ne na majagaba wanda aka keɓe don haɗa mutane da ke fuskantar ciwon daji na zamani tare da hanyoyin kwantar da hankali kamar CAR T-Cell far, TIL far, da gwaji na asibiti a duk duniya.

Bari mu san abin da za mu iya yi muku.

1) Maganin ciwon daji a kasashen waje?
2) CAR T-Cell far
3) rigakafin cutar daji
4) Shawarar bidiyo ta kan layi
5) Maganin Proton